Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 7,551 | 6,324 | 8,685 | 18,537 | 24,019 |
| Gross Profit | 7,551 | 6,324 | 8,685 | 18,537 | 24,019 |
| Operating Expenses | 100,063 | 84,654 | 81,629 | 70,759 | 69,731 |
| Operating Income | -92,512 | -78,330 | -72,944 | -52,222 | -45,712 |
| Other Income | 1,791 | 1,538 | 1,592 | 1,014 | 2,232 |
| Pre-tax Income | -90,721 | -76,792 | -71,352 | -51,208 | -43,480 |
| Income Tax | N/A | N/A | 431 | -431 | -22,091 |
| Net Income Continuous | -90,721 | -76,792 | -71,783 | -50,777 | -21,389 |
| Net Income | $-90,721 | $-76,792 | $-71,783 | $-50,777 | $-21,389 |
| EPS Basic Total Ops | -1.07 | -0.91 | -0.85 | -0.62 | 0.01 |
| EPS Basic Continuous Ops | -1.08 | -0.91 | -0.85 | -0.62 | 0.01 |
| EPS Diluted Total Ops | -1.07 | -0.91 | -0.85 | -0.62 | 0.01 |
| EPS Diluted Continuous Ops | -1.08 | -0.91 | -0.85 | -0.62 | 0.01 |
| EBITDA(a) | $-87,443 | $-73,060 | $-67,923 | $-48,532 | $-42,371 |